Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort study

BACKGROUND: Epidemiological evidence suggests the association of diabetes with an increased risk of stroke. Clinical studies have investigated the effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on new-onset stroke (NOS), but the results are inconsistent. OBJECTIVES: To determine the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tsung-Kun, Chen, Yong-Hsin, Huang, Jing-Yang, Liao, Pei-Lun, Chen, Mei-Chun, Pan, Lung-Fa, Jong, Gwo-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406283/
https://www.ncbi.nlm.nih.gov/pubmed/36035934
http://dx.doi.org/10.3389/fcvm.2022.966708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406283/
https://www.ncbi.nlm.nih.gov/pubmed/36035934
http://dx.doi.org/10.3389/fcvm.2022.966708

Ejemplares similares